Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | CA12 | O43570 | 3/20 | 0.38 |
| ▸ | MMP2 | P08253 | 2/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 2/20 | 0.30 |
| ▸ | TGM2 | P21980 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | MMP1 | P03956 | 1/20 | 0.30 |
| ▸ | MMP9 | P14780 | 1/20 | 0.30 |
| ▸ | MMP8 | P22894 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7141232 | 0.79 | TSHR (0.48) | TSHRCYP2C19ALDH1A1MAPK1TDP1 | |
| SCHEMBL1564157 | 0.77 | TSHR (0.58) | TSHRCA12MMP2CYP2C19ALDH1A1 | |
| SCHEMBL5489505 | 0.77 | TSHR (0.46) | TSHRCYP2C19ALDH1A1MAPK1TDP1 | |
| Phosphoric Acid SCHEMBL10755154 | 0.74 | TSHR (0.82) | TSHRCA12MMP2CYP2C19ALDH1A1 | |
| SCHEMBL491509 | 0.74 | TSHR (0.54) | TSHRCA12MMP2CYP2C19ALDH1A1 | |
| SCHEMBL5177219 | 0.73 | TSHR (0.52) | TSHRCA12MMP2CYP2C19ALDH1A1 | |
| SCHEMBL8384172 | 0.73 | TSHR (0.47) | TSHRCA12MMP2CYP2C19ALDH1A1 | |
| SCHEMBL2554848 | 0.70 | MMP1 (0.44) | TSHRCA12MMP2CYP2C19ALDH1A1 | |
| SCHEMBL337892 | 0.70 | TSHR (0.44) | TSHRCA12MMP2ALDH1A1MAPK1 | |
| SCHEMBL18297791 | 0.70 | TSHR (0.54) | TSHRCA12MMP2CYP2C19ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8097126-B2 | Aqueous composition and use thereof for paper production | BASF SE (DE) | 2012-01-17 | — | — | US | claimed |
| EP-1654419-B1 | AQUEOUS COMPOSITION AND USE THEREOF FOR PAPER PRODUCTION | BASF AG (DE) | 2006-11-08 | — | — | EP | claimed |
| US-20060037725-A1 | Aqueous composition and use thereof for paper production | BASF AKTIENGESELLSCHAFT (DE) | 2006-02-23 | — | — | US | claimed |
| US-20060024262-A1 | Aqueous composition and use thereof for paper production | BASF AKTIENGESELLSCHAFT (DE) | 2006-02-02 | — | — | US | claimed |
| WO-2024132736-A1 | PROCESS FOR MANUFACTURING A MULTI-LAYER PAPER OR CARDBOARD | BASF SE (DE) | 2024-06-27 | — | — | WO | disclosed |
| EP-3697964-B1 | METHOD FOR THE PREPARATION OF SINGLE LAYER OR MULTI-LAYER PAPER | SOLENIS TECHNOLOGIES CAYMAN LP (KY) | 2024-06-26 | — | — | EP | disclosed |
| EP-3697963-B1 | METHOD FOR PRODUCING MULTIPLE PLY PAPER | SOLENIS TECHNOLOGIES CAYMAN LP (KY) | 2024-06-26 | — | — | EP | disclosed |
| US-12018113-B2 | Method for the hydrolysis of a polymer | SOLENIS TECHNOLOGIES, L.P. (US) | 2024-06-25 | — | — | US | disclosed |
| EP-3695051-B1 | METHOD FOR FORMING PAPER OR CARDBOARD | SOLENIS TECHNOLOGIES CAYMAN LP (KY) | 2024-06-19 | — | — | EP | disclosed |
| EP-4363663-A1 | N-VINYLLACTAM-CONTAINING POLYMERS FOR PAPERMAKING | Solenis Technologies, L.P. (US) | 2024-05-08 | — | — | EP | disclosed |
| US-11680371-B2 | Method for producing multi-layer paper | SOLENIS TECHNOLOGIES, L.P. (US) | 2023-06-20 | — | — | US | disclosed |
| CN-113039223-B | Method for hydrolyzing polymer | 索理思科技开曼公司（KY） | 2023-01-13 | — | — | CN | disclosed |
| EP-1716836-A1 | Surface-modified fillers | Ivoclar Vivadent AG (LI) | 2006-11-02 | — | — | EP | disclosed |
| EP-1654419-A1 | AQUEOUS COMPOSITION AND USE THEREOF FOR PAPER PRODUCTION | BASF AKTIENGESELLSCHAFT (DE) | 2006-05-10 | — | — | EP | disclosed |
| US-20060037725-A1 | Aqueous composition and use thereof for paper production | BASF AKTIENGESELLSCHAFT (DE) | 2006-02-23 | — | — | US | disclosed |
| US-20060024262-A1 | Aqueous composition and use thereof for paper production | BASF AKTIENGESELLSCHAFT (DE) | 2006-02-02 | — | — | US | disclosed |
| WO-2005012637-A1 | AQUEOUS COMPOSITION AND USE THEREOF FOR PAPER PRODUCTION | BASF AKTIENGESELLSCHAFT (DE) | 2005-02-10 | — | — | WO | disclosed |
| EP-0909761-B1 | Hydrolysis-stable and polymerizable acryl phosphonic acids | IVOCLAR VIVADENT AG (LI) | 2003-04-02 | — | — | EP | disclosed |
| US-6172131-B1 | MADE BY REACTING AN ALPHA-HALOMETHACRYLIC ACID ESTER WITH PROTECTED MONO- OR DIFUNCTIONAL PHOSPHONIC ACID ESTERS; USE AS COMPONENT OF DENTAL ADHESIVES DUE TO THEIR ADHESION-PROMOTING PROPERTIES | IVOCLAR AG | 2001-01-09 | — | — | US | disclosed |
| EP-0909761-A1 | Hydrolysis-stable and polymerizable acryl phosphonic acids | IVOCLAR AG (LI) | 1999-04-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060024262-A1 | Aqueous composition and use thereof for paper production | CHMP4B, AQP1, IL17A | TSHR 4840/4885CA12 543/4885MMP2 1031/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.